Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.

Patel VM, Flanagan CE, Martins M, Jones CL, Butler RM, Woollard WJ, Bakr FS, Yoxall A, Begum N, Katan M, Whittaker SJ, Mitchell TJ.

J Invest Dermatol. 2019 Jul 31. pii: S0022-202X(19)32679-X. doi: 10.1016/j.jid.2019.07.693. [Epub ahead of print]

PMID:
31376383
2.

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.

Bagot M, Porcu P, Marie-Cardine A, Battistella M, William BM, Vermeer M, Whittaker S, Rotolo F, Ram-Wolff C, Khodadoust MS, Bensussan A, Paturel C, Bonnafous C, Sicard H, Azim HA Jr, Kim YH.

Lancet Oncol. 2019 Aug;20(8):1160-1170. doi: 10.1016/S1470-2045(19)30320-1. Epub 2019 Jun 25.

PMID:
31253572
3.

A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype.

Jue TR, Olafson LR, Siddell AH, Rapkins RW, Ng B, Yin JXM, Lu VM, Chung SA, Whittaker SP, Davies M, Fairhall JM, Hovey EJ, McDonald KL.

Cold Spring Harb Mol Case Stud. 2019 Jun 3;5(3). pii: a003251. doi: 10.1101/mcs.a003251. Print 2019 Jun.

4.

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 Jul;38(28):5746. doi: 10.1038/s41388-019-0835-1.

PMID:
31147600
5.

Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.

Butler RM, McKenzie RC, Jones CL, Flanagan CE, Woollard WJ, Demontis M, Ferreira S, Tosi I, John S, Whittaker SJ, Mitchell TJ.

J Invest Dermatol. 2019 Sep;139(9):1975-1984.e2. doi: 10.1016/j.jid.2019.03.1130. Epub 2019 Mar 22.

PMID:
30910759
6.

Controlling the dynamics of the Nek2 leucine zipper by engineering of "kinetic" disulphide bonds.

Gutmans DS, Whittaker SB, Asiani K, Atkinson RA, Oregioni A, Pfuhl M.

PLoS One. 2019 Feb 1;14(2):e0210352. doi: 10.1371/journal.pone.0210352. eCollection 2019.

7.

Epidural Analgesia Decreases Narcotic Requirements in Patients with Low Level Spina Bifida Undergoing Urological Laparotomy for Neurogenic Bladder and Bowel.

Roth JD, Misseri R, Whittaker SC, Monn MF, Horn ND, Cain MP, Green MC.

J Urol. 2019 Jan;201(1):169-173. doi: 10.1016/j.juro.2018.06.063.

PMID:
30577407
8.

The future of health systems to 2030: a roadmap for global progress and sustainability.

Braithwaite J, Mannion R, Matsuyama Y, Shekelle PG, Whittaker S, Al-Adawi S, Ludlow K, James W, Ting HP, Herkes J, McPherson E, Churruca K, Lamprell G, Ellis LA, Boyling C, Warwick M, Pomare C, Nicklin W, Hughes CF.

Int J Qual Health Care. 2018 Dec 1;30(10):823-831. doi: 10.1093/intqhc/mzy242.

PMID:
30576556
9.

British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.

Gilson D, Whittaker SJ, Child FJ, Scarisbrick JJ, Illidge TM, Parry EJ, Mohd Mustapa MF, Exton LS, Kanfer E, Rezvani K, Dearden CE, Morris SL.

Br J Dermatol. 2019 Mar;180(3):496-526. doi: 10.1111/bjd.17240. Epub 2018 Dec 17. No abstract available.

PMID:
30561020
10.

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 Mar;38(10):1717-1733. doi: 10.1038/s41388-018-0554-z. Epub 2018 Oct 23. Erratum in: Oncogene. 2019 May 30;:.

11.

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Child F, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R.

Br J Dermatol. 2019 Aug;181(2):350-357. doi: 10.1111/bjd.17258. Epub 2018 Nov 25.

PMID:
30267549
12.

Multilevel approaches to increase fruit and vegetable intake in low-income housing communities: final results of the 'Live Well, Viva Bien' cluster-randomized trial.

Gans KM, Risica PM, Keita AD, Dionne L, Mello J, Stowers KC, Papandonatos G, Whittaker S, Gorham G.

Int J Behav Nutr Phys Act. 2018 Aug 20;15(1):80. doi: 10.1186/s12966-018-0704-2.

13.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators.

Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581.

PMID:
30100375
14.

Primary cutaneous CD30+ anaplastic large-cell lymphoma associated with fingolimod.

Connolly A, Grandi V, Stefanato CM, Palmer R, Weir A, Whittaker S.

Br J Dermatol. 2018 Dec;179(6):1400-1401. doi: 10.1111/bjd.17003. Epub 2018 Oct 10. No abstract available.

PMID:
30007065
15.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2019 Mar 1;30(3):494. doi: 10.1093/annonc/mdy207. No abstract available.

PMID:
29947731
16.

Long-distance stone transport and pigment use in the earliest Middle Stone Age.

Brooks AS, Yellen JE, Potts R, Behrensmeyer AK, Deino AL, Leslie DE, Ambrose SH, Ferguson JR, d'Errico F, Zipkin AM, Whittaker S, Post J, Veatch EG, Foecke K, Clark JB.

Science. 2018 Apr 6;360(6384):90-94. doi: 10.1126/science.aao2646. Epub 2018 Mar 15.

PMID:
29545508
17.

'It's a traumatic illness, traumatic to witness': a qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.

Orlowska D, Selman LE, Beynon T, Radcliffe E, Whittaker S, Child F, Harding R.

Br J Dermatol. 2018 Oct;179(4):882-888. doi: 10.1111/bjd.16447. Epub 2018 Jun 19.

PMID:
29451670
18.

Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.

Whittaker SR, Barlow C, Martin MP, Mancusi C, Wagner S, Self A, Barrie E, Te Poele R, Sharp S, Brown N, Wilson S, Jackson W, Fischer PM, Clarke PA, Walton MI, McDonald E, Blagg J, Noble M, Garrett MD, Workman P.

Mol Oncol. 2018 Mar;12(3):287-304. doi: 10.1002/1878-0261.12148. Epub 2018 Jan 28.

19.

Accomplishing reform: successful case studies drawn from the health systems of 60 countries.

Braithwaite J, Mannion R, Matsuyama Y, Shekelle P, Whittaker S, Al-Adawi S, Ludlow K, James W, Ting HP, Herkes J, Ellis LA, Churruca K, Nicklin W, Hughes C.

Int J Qual Health Care. 2017 Oct 1;29(6):880-886. doi: 10.1093/intqhc/mzx122.

20.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352. Erratum in: Ann Oncol. 2019 Mar 1;30(3):494.

PMID:
28961843
21.

Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy.

Duvic M, Bates SE, Piekarz R, Eisch R, Kim YH, Lerner A, Robak T, Samtsov A, Becker JC, McCulloch W, Waksman J, Whittaker S.

Leuk Lymphoma. 2018 Apr;59(4):880-887. doi: 10.1080/10428194.2017.1361022. Epub 2017 Aug 30.

PMID:
28853310
22.

The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.

Morris S, Scarisbrick J, Frew J, Irwin C, Grieve R, Humber C, Kuciejewska A, Bayne S, Weatherhead S, Child F, Wain M, Whittaker S.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):627-633. doi: 10.1016/j.ijrobp.2017.05.052. Epub 2017 Jun 9.

PMID:
28843374
23.

U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma.

Sanyal S, Child F, Alfred A, Callaghan T, Alband N, Whittaker S, Cowan R, Parry E, Robinson S, Dunnill MGS, Wain M, Morris S, Malladi R, Tahir S, Howles A, Arumainathan A, Azurdia R, Grant-Casey J, Matin RN, Gilson D, Howell C, El-Gheriani K, Taylor P, Scarisbrick J.

Br J Dermatol. 2018 Feb;178(2):569-570. doi: 10.1111/bjd.15871. Epub 2018 Jan 12. No abstract available.

PMID:
28782100
24.

Combination of palbociclib and radiotherapy for glioblastoma.

Whittaker S, Madani D, Joshi S, Chung SA, Johns T, Day B, Khasraw M, McDonald KL.

Cell Death Discov. 2017 Jul 3;3:17033. doi: 10.1038/cddiscovery.2017.33. eCollection 2017.

25.

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group.

Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.

PMID:
28600132
26.

Modifying illness beliefs in recent onset psychosis carers: Evaluating the impact of a cognitively focused brief group intervention in a routine service.

Onwumere J, Glover N, Whittaker S, Rahim S, Chu Man L, James G, Khan S, Afsharzadegan R, Seneviratne S, Harvey R, Georgiades A, Raune D.

Early Interv Psychiatry. 2018 Dec;12(6):1144-1150. doi: 10.1111/eip.12430. Epub 2017 May 18.

PMID:
28517041
27.

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.

Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E, Marreaud S, Morris S, Dalle S, Servitje O, Cowan R, Väkevä L, Chaby G, Jonak C, Fox CP, Ritchie D, Vermeer MH, Stadler R, Romero PLO, Scarisbrick J, Quaglino P.

Eur J Dermatol. 2017 Jun 1;27(3):286-294. doi: 10.1684/ejd.2017.3008.

PMID:
28468739
28.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

29.

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.

Jue TR, Nozue K, Lester AJ, Joshi S, Schroder LB, Whittaker SP, Nixdorf S, Rapkins RW, Khasraw M, McDonald KL.

J Transl Med. 2017 Mar 17;15(1):61. doi: 10.1186/s12967-017-1164-1.

30.

Diffuse large B-cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.

Chan BCY, Stefanato CM, Moonim MT, Morris SL, Fields P, Dasgupta D, Therianou A, Whittaker SJ.

Br J Dermatol. 2017 Oct;177(4):e138-e140. doi: 10.1111/bjd.15460. Epub 2017 Sep 11. No abstract available.

PMID:
28301708
31.

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma.

Girotti MR, Lopes F, Preece N, Niculescu-Duvaz D, Zambon A, Davies L, Whittaker S, Saturno G, Viros A, Pedersen M, Suijkerbuijk BMJM, Menard D, McLeary R, Johnson L, Fish L, Ejiama S, Sanchez-Laorden B, Hohloch J, Carragher N, Macleod K, Ashton G, Marusiak AA, Fusi A, Brognard J, Frame M, Lorigan P, Marais R, Springer C.

Cancer Cell. 2017 Mar 13;31(3):466. doi: 10.1016/j.ccell.2017.02.007. No abstract available.

32.

Inhibitors of cyclin-dependent kinases as cancer therapeutics.

Whittaker SR, Mallinger A, Workman P, Clarke PA.

Pharmacol Ther. 2017 May;173:83-105. doi: 10.1016/j.pharmthera.2017.02.008. Epub 2017 Feb 5. Review.

33.

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).

Pinter T, Klippel Z, Cesas A, Croitoru A, Decaestecker J, Gibbs P, Hotko Y, Jassem J, Kurteva G, Novotny J, O'Reilly S, Salek T, Reiner M, Morrow PK, Choi MR, Whittaker S, Blanke C.

Clin Colorectal Cancer. 2017 Jun;16(2):103-114.e3. doi: 10.1016/j.clcc.2016.08.008. Epub 2016 Sep 7.

PMID:
28038865
34.

Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.

Boonk SE, Zoutman WH, Putter H, Ram-Wolff C, Felcht M, Klemke CD, Ranki A, Quaglino P, Whittaker S, Bagot M, Willemze R, Vermeer MH.

J Invest Dermatol. 2017 Mar;137(3):754-757. doi: 10.1016/j.jid.2016.10.025. Epub 2016 Oct 28. No abstract available.

35.

Nonhealing surgical wound due to cutaneous malakoplakia.

Alwan W, Rickaby W, Jullie ML, Green M, Ypsilantis E, Warbey V, George M, Whittaker S.

Clin Exp Dermatol. 2017 Jan;42(1):123-125. doi: 10.1111/ced.12972. Epub 2016 Dec 9. No abstract available.

PMID:
27935636
36.

Applying Concept Mapping Methodology to Identify the Perceptions of Risk and Protective Factors for Childhood Obesity among Southeast Asian Refugees.

Keita AD, Whittaker S, Wynter J, Kidanu TW, Chhay C, Cardel M, Gans KM.

J Health Care Poor Underserved. 2016;27(4):1909-1933.

PMID:
27818447
37.

Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides.

Foss F, Duvic M, Lerner A, Waksman J, Whittaker S.

Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):637-643. doi: 10.1016/j.clml.2016.08.009. Epub 2016 Aug 10.

38.

Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma.

Whittaker S.

J Invest Dermatol. 2016 Sep;136(9):1753-1754. doi: 10.1016/j.jid.2016.05.114. Review.

39.

Technology and Reflection: Mood and Memory Mechanisms for Well-Being.

Konrad A, Tucker S, Crane J, Whittaker S.

Psychol Well Being. 2016;6:5. Epub 2016 Jun 15.

40.

How I treat mycosis fungoides and Sézary syndrome.

Whittaker S, Hoppe R, Prince HM.

Blood. 2016 Jun 23;127(25):3142-53. doi: 10.1182/blood-2015-12-611830. Epub 2016 May 5.

PMID:
27151889
41.

Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.

Woollard WJ, Pullabhatla V, Lorenc A, Patel VM, Butler RM, Bayega A, Begum N, Bakr F, Dedhia K, Fisher J, Aguilar-Duran S, Flanagan C, Ghasemi AA, Hoffmann RM, Castillo-Mosquera N, Nuttall EA, Paul A, Roberts CA, Solomonidis EG, Tarrant R, Yoxall A, Beyers CZ, Ferreira S, Tosi I, Simpson MA, de Rinaldis E, Mitchell TJ, Whittaker SJ.

Blood. 2016 Jun 30;127(26):3387-97. doi: 10.1182/blood-2016-02-699843. Epub 2016 Apr 27.

PMID:
27121473
42.

Occupational exposures to new dry cleaning solvents: High-flashpoint hydrocarbons and butylal.

Ceballos DM, Whittaker SG, Lee EG, Roberts J, Streicher R, Nourian F, Gong W, Broadwater K.

J Occup Environ Hyg. 2016 Oct 2;13(10):759-69. doi: 10.1080/15459624.2016.1177648.

43.

Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.

Boonk SE, Zoutman WH, Marie-Cardine A, van der Fits L, Out-Luiting JJ, Mitchell TJ, Tosi I, Morris SL, Moriarty B, Booken N, Felcht M, Quaglino P, Ponti R, Barberio E, Ram-Wolff C, Jäntti K, Ranki A, Bernengo MG, Klemke CD, Bensussan A, Michel L, Whittaker S, Bagot M, Tensen CP, Willemze R, Vermeer MH.

J Invest Dermatol. 2016 Jul;136(7):1364-1372. doi: 10.1016/j.jid.2016.01.038. Epub 2016 Feb 28.

44.

Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.

Woollard WJ, Kalaivani NP, Jones CL, Roper C, Tung L, Lee JJ, Thomas BR, Tosi I, Ferreira S, Beyers CZ, McKenzie RCT, Butler RM, Lorenc A, Whittaker SJ, Mitchell TJ.

J Invest Dermatol. 2016 Jun;136(6):1238-1246. doi: 10.1016/j.jid.2016.01.028. Epub 2016 Feb 9.

45.

Framework for the assessment of interaction between CO2 geological storage and other sedimentary basin resources.

Michael K, Whittaker S, Varma S, Bekele E, Langhi L, Hodgkinson J, Harris B.

Environ Sci Process Impacts. 2016 Feb;18(2):164-75. doi: 10.1039/c5em00539f.

PMID:
26767550
46.

Improving the quality of service delivery in South Africa Healthcare Establishments.

Whittaker S, Mazwai L.

World Hosp Health Serv. 2016;52(3):42-45.

PMID:
30707814
47.

Question 2: Do standing frames and other related physical therapies reduce the risk of fractures in children with cerebral palsy?

Whittaker S, Tomlinson R.

Arch Dis Child. 2015 Dec;100(12):1181-3. doi: 10.1136/archdischild-2015-309460. Review. No abstract available.

PMID:
26586521
48.

Use Catholic Tradition To Guide Telehealth.

Whittaker S, Cox J.

Health Prog. 2015 Jan-Feb;96(1):51-5. No abstract available.

PMID:
26571876
49.

Characterization of "Hydrocarbon" Dry Cleaning in King County, Washington.

Whittaker SG, Taylor J, Van Hooser LM.

J Environ Health. 2015 Sep;78(2):8-13.

PMID:
26502560
50.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

Supplemental Content

Loading ...
Support Center